MEDGENICS, INC.·4

Feb 20, 6:13 AM ET

MEDGENICS, INC. 4

4 · MEDGENICS, INC. · Filed Feb 20, 2015

Insider Transaction Report

Form 4
Period: 2015-02-18
Leaman John Harold
Chief Financial Officer
Transactions
  • Award

    Option Award (right to buy)

    2015-02-18+140,000140,000 total
    Exercise: $7.01Exp: 2025-02-18Common Stock (140,000 underlying)
Footnotes (1)
  • [F1]The option award vests in four equal installments on February 18, 2016, 2017, 2018 and 2019.

Documents

2 files